Stella Pharma Corporation (TYO:4888)

Revenue by Product

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Pharmaceutical	269.49M	Log In	Log In	Log In
Pharmaceutical Growth	17.65%	Log In	Log In	Log In

Revenue by Geography

Fiscal year is April - March.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Japan	269.49M	Log In	Log In	Log In
Japan Growth	17.65%	Log In	Log In	Log In